![]() |
|
|
Vol. 282, Issue 3, 1206-1212, 1997
Center for Basic Research in Digestive Diseases, Mayo Clinic and
Foundation, Rochester, Minnesota
The mouse cholecystokinin (CCK) receptor is functionally distinct from
the extensively studied rat receptor on the basis of differences in
binding and biological activity of phenethyl ester analogs of CCK.
These are partial agonists at the rat receptor and full agonists at the
mouse pancreatic receptor. To explore this, we cloned the cDNA for the
mouse type A CCK receptor, established a receptor-bearing Chinese
hamster ovary (CHO) cell line and characterized its binding and
biological characteristics. Despite 25 differences in amino acid
sequence from the rat receptor, including a seven-amino acid insertion
in the third intracellular loop, mouse and rat receptors were
functionally indistinguishable when expressed in CHO cells. Of note, in
the mouse pancreatic cell environment, a stable analog of guanosine
triphosphate significantly inhibited binding of CCK-OPE, whereas it had
no effect on binding to the same receptor on the CHO-CCKM cell line or
to the rat receptor in either environment of the acinar cell. This
likely reflects a difference in coupling of the mouse receptor to its G
protein in the natural environment of the acinar cell. This may relate to differences extrinsic to the receptor, in the stoichiometry or
character of G proteins or in the composition or organization of the
lipid environment of the mouse acinar cell membrane. Although this may
require complementation of the unique sequence of the mouse receptor,
that structure alone is insufficient to explain this phenomenon.
Receptor microenvironment makes an important, yet often ignored,
contribution to receptor function.
This article has been cited by other articles:
![]() |
B. J. Wang and Z. J. Cui How does cholecystokinin stimulate exocrine pancreatic secretion? From birds, rodents, to humans Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R666 - R678. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dufresne, C. Seva, and D. Fourmy Cholecystokinin and gastrin receptors. Physiol Rev, July 1, 2006; 86(3): 805 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Holicky, E. M. Hadac, X.-Q. Ding, and L. J. Miller Molecular characterization and organ distribution of type A and B cholecystokinin receptors in cynomolgus monkey Am J Physiol Gastrointest Liver Physiol, August 1, 2001; 281(2): G507 - G514. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Poosti, L. di Malta, D. Gagne, N. Bernad, J.-C. Galleyrand, C. Escrieut, S. Silvente-Poirot, D. Fourmy, and J. Martinez The Third Intracellular Loop of the Rat and Mouse Cholecystokinin-A Receptors Is Responsible for Different Patterns of Gene Activation Mol. Pharmacol., April 13, 2001; 58(6): 1381 - 1388. [Abstract] [Full Text] |
||||
![]() |
N. B. Keele, F. Zinebi, V. Neugebauer, and P. Shinnick-Gallagher Epileptogenesis Up-Regulates Metabotropic Glutamate Receptor Activation of Sodium-Calcium Exchange Current in the Amygdala J Neurophysiol, April 1, 2000; 83(4): 2458 - 2462. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ji, A. S. Kopin, and C. D. Logsdon Species Differences between Rat and Mouse CCKA Receptors Determine the Divergent Acinar Cell Response to the Cholecystokinin Analog JMV-180 J. Biol. Chem., June 16, 2000; 275(25): 19115 - 19120. [Abstract] [Full Text] [PDF] |
||||